Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-25-078076
Filing Date
2025-08-14
Accepted
2025-08-14 07:10:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 S-3/A tm2523396d1_s3a.htm S-3/A 40901
2 EXHIBIT 23.1 tm2523396d1_ex23-1.htm EX-23.1 3913
3 GRAPHIC tm2523396d1_ex23-1img01.jpg GRAPHIC 2336
  Complete submission text file 0001104659-25-078076.txt   49444
Mailing Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601
Business Address 2 UNIVERSITY PLAZA SUITE 100 HACKENSACK NJ 07601 201-696-9345
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-286802 | Film No.: 251214273
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)